retatrutide phase 2 trial obesity nejm 2023 What is Retatrutide: Phase 3 Results (Up

It blends science-based GLP-1 microdosing with lifestyle guidance thats easy to follow, and the fact is that many fitness-minded patients want control, not dramatic changes

Clinical Trial Results SURMOUNT-1 trial: Average weight loss of ~20% of total body weight

Liraglutide (LEADER trial), semaglutide (SUSTAIN-6), and dulaglutide (REWIND trial) demonstrated significant reductions in major adverse cardiovascular events, while others showed cardiovascular safety without superiority

Because obviously not every doctor is trained in hormones and endocrine system

"Best" in this context does not mean a product endorsement or ranking

If you dont lose at least 10% of your body weight, you get a full refund